FIS will attend CPhI Worldwide, the most important international event dedicated to the chemical and pharmaceutical industry. 

Now in its 33rd year, the event will take place from 1 November to 3 November in Frankfurt and will involve over 100,000 industry professionals in conferences, meetings, webinars and online communities. FIS will appear at stand 80B71.

CPhI represents a unique opportunity for FIS this year to increase its market share in the generic drug sector through the newly formed Generics commercial division led by Gianluca Schiavoni. As for the Custom division, which has been entrusted to Luca Parlanti, the goal is to consolidate FIS' position as a long-term partner for the most important pharmaceutical companies worldwide. Due to a 14% increase in revenues to 562 million euros in 2021, growth in the custom drug sector amounted to 23%, a trend that is also being confirmed in 2022. 

In 2021, FIS recorded revenues of 562 million euros, a 14% increase compared to the previous year. 71% of revenues were generated in Europe (10% in Italy), 16% in America, 12% in Asia and 1% in the rest of the world. 

Gianluca Schiavoni and Luca Parlanti, Sales Directors for FIS commented: “We are excited to participate in one of our industry's most important events. We've scheduled about fifty meetings that will involve current and potential customers. We're interested in the opportunities on both the generic and custom product markets and will make the most of the benefits that an event of this size offers us. In this particular moment in history, it's even more important to be able to listen to the needs of our stakeholders and to be able to confirm our role as a long-term supplier able to combine growth and social responsibility”.